WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS)

$12.93 0.09 (0.7009%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 79

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS) News Sources

WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic

13-01-2026

yahoo.com

Vertex Partners With WuXi To Broaden Autoimmune Pipeline Beyond Cystic Fibrosis

10-02-2026

yahoo.com

Vertex Autoimmune Deal With WuXi Adds New Angle To VRTX Valuation Story

15-02-2026

yahoo.com

WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS) Sentiment Trend

0 25 50 75 100 63 91 83 13-01-2026 10-02-2026 15-02-2026 #1 #2 #3 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS) FAQs

toggle

What is the current price of WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS)?

The current price of WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS) is $12.93.


toggle

WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS) absolute price change since previous trading day?

The absolute price change of WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS) since the previous trading day is $0.09.


toggle

WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS) percentage price change since previous trading day?

The percentage price change of WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS) since the previous trading day is 0.7009%.


toggle

What is the most recent average sentiment score for WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS)?

The most recent average sentiment score for WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS) is 79 out of 100.


toggle

What is the most recent average sentiment for WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS)?

The most recent sentiment for WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS) is .


SEC-8K** Filing Available For WUXI BIOLOGICS CAYMAN - ADR (WXXWY:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.